SCHEMBL22359274

SCHEMBL22359274

CS(=O)(=O)C1CC[C@@H]1Nc1nc(N2CCCC(N)C2)cnc1C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 18/20 0.53
▸ JAK3 P52333 13/20 0.53
▸ LCK P06239 9/20 0.52
▸ EGFR P00533 6/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22346053 0.79 BTK (0.74) BTKJAK3LCKEGFR
SCHEMBL22358871 0.79 BTK (0.74) BTKJAK3LCKEGFR
SCHEMBL22346874 0.79 BTK (0.74) BTKJAK3LCKEGFR
SCHEMBL22346882 0.75 BTK (0.64) BTKJAK3LCKEGFR
SCHEMBL29871745 0.75 BTK (0.64) BTKJAK3LCKEGFR
SCHEMBL22346873 0.75 BTK (0.64) BTKJAK3LCKEGFR
SCHEMBL18296430 0.75 BTK (0.64) BTKJAK3LCKEGFR
SCHEMBL18296292 0.75 BTK (0.55) BTKJAK3LCKEGFR
SCHEMBL25607781 0.74 BTK (0.49) BTKJAK3LCKEGFR
SCHEMBL18283479 0.73 BTK (0.74) BTKJAK3LCKEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020167518-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY NURIX THERAPEUTICS, INC. (US) 2020-08-20 — — WO disclosed
Send feedback